This is consistent with a recent research conducted by Tiosano et al., in which a group of patients with a relatively stable intermediate AMD followed with OCTA, showed a significant CC impairment deterioration over one year of follow up, suggesting that CC dysfunction occurs before any structural change (43). The gene discussed is CXCR1; the disease is age-related macular degeneration.